Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Overactivation of the NLRP3 Inflammasome in Chronic Myelomonocytic Leukemia KRAS Mutated Patients Can be Detected By the Apoptosis-Associated Speck-like Protein (ASC) and Reverted By IL1β Inhibitors

Blood (2021) 138 (Supplement 1): 3670.

DOI: https://doi.org/10.1182/blood-2021-153686

Published: 2021

Journal Articles

Low-Risk Polycythemia Vera Treated with Phlebotomies: Clinical Characteristics, Hematologic Control and Complications in 358 Patients from the Spanish Registry of Polycythemia Vera

Blood (2021) 138 (Supplement 1): 3621.

DOI: https://doi.org/10.1182/blood-2021-145012

Published: 2021

Journal Articles

Hydroxyurea Reduces Neutrophil Extracellular Trap Formation in Myeloproliferative Neoplasms

Ernesto J Cuenca, Nieves García Gisbert, BSc, Ascensión M de Los Reyes-García, PhDStudent, Cristina Aroca, MD, Lorena Martinez-Montesinos, MD, Marcio Andrade, MD PhD, Sonia Aguila, PhD, Pedro J Guijarro-Carrillo, Rosa Cifuentes-Riquelme, PhDStudent, Rocio González-Conejero, PhD, Constantino Martínez, PhD, Vicente Vicente, MD PhD, Alberto Alvarez-Larrán, MD, Beatriz Bellosillo, PhD, Raul Teruel-Montoya, PhD, Francisca Ferrer Marin, MD PhD

Blood (2020) 136 (Supplement 1): 20–21.

DOI: https://doi.org/10.1182/blood-2020-139368

Published: 2020

Journal Articles

Different Clinical Implications of Kinase Domain BCR-ABL1 Variants Detected in Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia Patients

Blood (2019) 134 (Supplement_1): 5368.

DOI: https://doi.org/10.1182/blood-2019-127069

Published: 2019

Journal Articles

Clinical Characteristics and Cardioavscular Events in Patients with Esential Thrombocythemia with <10% Vs. ≥10% JAK2 V617F Allele Burden

Blood (2019) 134 (Supplement_1): 4171.

DOI: https://doi.org/10.1182/blood-2019-126980

Published: 2019

Journal Articles

Strategies for Analysis of Novel Molecular Variants in the RUNX1 Gene As a Cause of Familial Platelet Disorder with Predisposition to Acute Myeloid Leukemia (FPD/AML)

Veronica Palma-Barqueros, MSc, Jf Ruiz-Pividal, MSc, Jose Maria Bastida, MD PhD, Natalia Bohdan, MJ Lopez-Andreu, PhD, Raul Teruel-Montoya, PhD, Ana Isabel Antón, PhD, Francisca Ferrer Marin, MD PhD, Jose Padilla, Rosa Cifuentes-Riquelme, A Marín-Quilez, MSc, Marta Martín Izquierdo, MSc, Rocio Benito, PhD, Vicente Vicente, MD PhD, Jesus Maria . Hernández-Rivas, MD, José Ramón González-Porras, MD PhD, Jose Rivera, PhD, Maria Luisa Lozano, MD PhD

Blood (2019) 134 (Supplement_1): 2359.

DOI: https://doi.org/10.1182/blood-2019-128736

Published: 2019

Journal Articles

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Blood (2018) 132 (Supplement 1): 3072.

DOI: https://doi.org/10.1182/blood-2018-99-119221

Published: 2018

Journal Articles

Excess Mortality in Polycythemia Vera and Essential Thrombocythemia

Arturo Pereira, MD PhD, Carlos Besses Raebel, MD PhD, Juan Carlos Hernandez Boluda, MD PhD, Francisca Ferrer Marin, MD PhD, Carmen Garcia-Hernandez, MD, María Teresa Gómez-Casares, MD PhD, Manuel Pérez-Encinas, MD, María-Soledad Noya, MD, Beatriz Cuevas, MD, Gonzalo Caballero, MD, Maribel Mata, Francisco Cervantes, MD PhD, Alberto Alvarez-Larrán, MD PhD

Blood (2018) 132 (Supplement 1): 3042.

DOI: https://doi.org/10.1182/blood-2018-99-109892

Published: 2018

Journal Articles

Feasibility of Treatment Discontinuation in Chronic Myeloid Leukemia in Clinical Practice in Spain: Results from a Nationwide Series of 236 Patients

Blood (2018) 132 (Supplement 1): 47.

DOI: https://doi.org/10.1182/blood-2018-99-109976

Published: 2018

Journal Articles

Transcriptome of DNA Repair Genes in CMML: Rationale for Targeting ERCC1 and CDKN1A As a Synthetic Lethality Approach

Blood (2017) 130 (Supplement 1): 1679.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1679.1679

Published: 2017

Journal Articles

Novel mutations in RASGRP2 , which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction

María Luisa Lozano, Aaron Cook, José María Bastida, David S. Paul, Gemma Iruin, Ana Rosa Cid, Rosa Adan-Pedroso, José Ramón González-Porras, Jesús María Hernández-Rivas, Sarah J. Fletcher, Ben Johnson, Neil Morgan, Francisca Ferrer-Marin, Vicente Vicente, John Sondek, Steve P. Watson, Wolfgang Bergmeier, José Rivera

Blood (2016) 128 (9): 1282–1289.

DOI: https://doi.org/10.1182/blood-2015-11-683102

Published: 2016

Includes: Supplemental data

Journal Articles

Measurement of PTCH1 Expression at Diagnosis Is an Appropriate Tool for Tyrosine Kinase Inhibitors Selection in Chronic Myeloid Leukemia Patients in Chronic Phase

Juan Manuel Alonso-Dominguez, MD, Felipe Casado, MariaTeresa Gómez Casares, MDPhD, Ismael Buno, Francisca Ferrer-Marin, Eduardo Anguita, MD PhD, Alicia Arenas, Rafael Del Orbe, MD, Rosa M. Ayala, MD PhD, Pilar Llamas, MD, Pedro Sanchez-Godoy, MD, Carmen Burgaleta, MD, Valentín García-Gutierrez, Juan Luis Steegmann, MD PhD, Joaquin Martinez-Lopez

Blood (2015) 126 (23): 2791.

DOI: https://doi.org/10.1182/blood.V126.23.2791.2791

Published: 2015

Journal Articles

A Study of the Role of Antiplatelet Therapy in the Prevention of Thrombosis in Patients with Calr -Mutated Low Risk Essential Thrombocythemia

Blood (2015) 126 (23): 1602.

DOI: https://doi.org/10.1182/blood.V126.23.1602.1602

Published: 2015

Journal Articles

Downregulation of BAP1 in Chronic Myelomonocytic Leukemia: Correlated with a Post-Translational Reduction of BRCA1 Levels and Independent of Promoter Methylation

Ana María Hurtado, Gines Luengo-Gil, Laura Palomo, MSc, Eva Lumbreras, Eva Caparrós, Tzu Hua Chen-Liang, Bartlomiej Przychodzen, MSc, Maria Luz Amigo, María Díez-Campelo, MD PhD, Lurdes Zamora, PhD, Francisco José Ortuño, Raul Teruel Montoya, PhD, Jaroslaw P. Maciejewski, MD PhD, Consuelo Del Cañizo, MD PhD, Francesc Sole, PhD, Francisca Ferrer-Marin, Andres Jerez

Blood (2015) 126 (23): 1648.

DOI: https://doi.org/10.1182/blood.V126.23.1648.1648

Published: 2015

Journal Articles

Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies

Zhi-Jian Liu, James B. Bussel, Madhavi Lakkaraja, Francisca Ferrer-Marin, Cedric Ghevaert, Henry A. Feldman, Janice G. McFarland, Chaitanya Chavda, Martha Sola-Visner

Blood (2015) 126 (10): 1234–1236.

DOI: https://doi.org/10.1182/blood-2014-11-611020

Published: 2015

Includes: Supplemental data

Journal Articles

Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia

Ana Maria Hurtado, Eva Caparrós, Jose Miguel Torregrosa, Ginés Luengo, Mara Toderici, María Eugenia De la Morena, Begoña Muiña, Maria Luisa Lozano, Constant Martinez, Mari Luz Amigo, Felipe De Arriba, Francisco Ortuño, Raul Teruel Montoya, PhD, Francisca Ferrer-Marin, MD, PhD, Vicente Vicente, MD PhD, Andres Jerez, MD PhD

Blood (2014) 124 (21): 5594.

DOI: https://doi.org/10.1182/blood.V124.21.5594.5594

Published: 2014

Journal Articles

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Alberto Alvarez-Larrán, Arturo Pereira, Francisco Cervantes, Eduardo Arellano-Rodrigo, Juan-Carlos Hernández-Boluda, Francisca Ferrer-Marín, Anna Angona, Montse Gómez, Begoña Muiña, Helga Guillén, Anabel Teruel, Beatriz Bellosillo, Carmen Burgaleta, Vicente Vicente, Carles Besses

Blood (2012) 119 (6): 1363–1369.

DOI: https://doi.org/10.1182/blood-2011-10-387787

Published: 2012

Journal Articles

Prolonged Survival of Neonatal Platelets Helps Meet the High Platelet Demand During This Period of Rapid Growth, and Is Associated with High Bcl-2 Levels

Zhi-Jian Liu, Ph.D., Karin M. Hoffmeister, MD, Zhongbo Hu, MD, PhD, Chaitanya Chavda, MD, Francisca Ferrer-Marin, M.D., Ph.D., Martha Sola-Visner, MD

Blood (2011) 118 (21): 706.

DOI: https://doi.org/10.1182/blood.V118.21.706.706

Published: 2011

Journal Articles

Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes

Zhi-Jian Liu, Joseph Italiano, Jr, Francisca Ferrer-Marin, Ravi Gutti, Matthew Bailey, Brandon Poterjoy, Lisa Rimsza, Martha Sola-Visner

Blood (2011) 117 (15): 4106–4117.

DOI: https://doi.org/10.1182/blood-2010-07-293092

Published: 2011

Includes: Supplemental data

Journal Articles

Developmental Differences In the Let-7b/IMP-1/IGF-II Axis contribute to the High Proliferative Rate of Neonatal Megakaryocyte Progenitors.

Ravi K. Gutti, PhD, Hannes Sallmon, Zhi-Jian Liu, PhD, Francisca Ferrer-Marin, MD, PhD, Alan Cantor, MD, PhD, Matthew Bailey, BS, Martha Sola-Visner, MD

Blood (2010) 116 (21): 1598.

DOI: https://doi.org/10.1182/blood.V116.21.1598.1598

Published: 2010

NARROW

Overactivation of the NLRP3 Inflammasome in Chronic Myelomonocytic Leukemia KRAS Mutated Patients Can be Detected By the Apoptosis-Associated Speck-like Protein (ASC) and Reverted By IL1β Inhibitors

Low-Risk Polycythemia Vera Treated with Phlebotomies: Clinical Characteristics, Hematologic Control and Complications in 358 Patients from the Spanish Registry of Polycythemia Vera

Hydroxyurea Reduces Neutrophil Extracellular Trap Formation in Myeloproliferative Neoplasms

Different Clinical Implications of Kinase Domain BCR-ABL1 Variants Detected in Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia Patients

Clinical Characteristics and Cardioavscular Events in Patients with Esential Thrombocythemia with <10% Vs. ≥10% JAK2 V617F Allele Burden

Strategies for Analysis of Novel Molecular Variants in the RUNX1 Gene As a Cause of Familial Platelet Disorder with Predisposition to Acute Myeloid Leukemia (FPD/AML)

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Excess Mortality in Polycythemia Vera and Essential Thrombocythemia

Feasibility of Treatment Discontinuation in Chronic Myeloid Leukemia in Clinical Practice in Spain: Results from a Nationwide Series of 236 Patients

Transcriptome of DNA Repair Genes in CMML: Rationale for Targeting ERCC1 and CDKN1A As a Synthetic Lethality Approach

Novel mutations in RASGRP2 , which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction

Measurement of PTCH1 Expression at Diagnosis Is an Appropriate Tool for Tyrosine Kinase Inhibitors Selection in Chronic Myeloid Leukemia Patients in Chronic Phase

A Study of the Role of Antiplatelet Therapy in the Prevention of Thrombosis in Patients with Calr -Mutated Low Risk Essential Thrombocythemia

Downregulation of BAP1 in Chronic Myelomonocytic Leukemia: Correlated with a Post-Translational Reduction of BRCA1 Levels and Independent of Promoter Methylation

Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies

Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Prolonged Survival of Neonatal Platelets Helps Meet the High Platelet Demand During This Period of Rapid Growth, and Is Associated with High Bcl-2 Levels

Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes

Developmental Differences In the Let-7b/IMP-1/IGF-II Axis contribute to the High Proliferative Rate of Neonatal Megakaryocyte Progenitors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only